Reply to comments on "Impact of EUCAST rapid Antimicrobial Susceptibility testing (RAST) on management of Gram-negative bloodstream infection"

Infect Dis Now. 2023 Mar;53(2):104667. doi: 10.1016/j.idnow.2023.104667. Epub 2023 Feb 2.

Authors

E Cardot-Martin¹, M A Colombier², L Limousin³, E Farfour³, P Lesprit⁴, M Vasse³

Affiliations

¹ Microbiology Unit, Foch Hospital, 92150 Suresnes, France. Electronic address: [email protected].
² Infectious Disease Unit and Internal Medicine Unit, Foch Hospital, 92150 Suresnes, France.
³ Microbiology Unit, Foch Hospital, 92150 Suresnes, France.
⁴ Infectious Disease Unit, Foch Hospital, 92150 Suresnes, France.

PMID: 36736825
DOI: 10.1016/j.idnow.2023.104667

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents* / pharmacology
Anti-Bacterial Agents* / therapeutic use
Humans
Sepsis* / drug therapy

Substances

Anti-Bacterial Agents